Biostar Pharmaceuticals, Inc. (BSPM)

[GorillaGorilla]

Thanks Joe & Bogus - Interestingly in Q1 there was no Y/Y growth for the capsule.

Q1 2009 $ 3,836,680
Q1 2008 $ 3,887,380

In Q2 the growth was attibuted by the expansion into new provincies [1]...

"The increase in revenues resulted from Biostar's enhanced marketing and sales efforts which increased sales of its Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing Capsule") and Tianqi Dysmenorrhea Capsules ("Tainqi Capsule"). Xin Aoxing Capsule, one of Biostar's flagship OTC products which treats symptoms common to hepatitis B patients, contributed approximately 67.5% to total revenues for the quarter, and increased $4.1 million, or 84.1% to $8.9 million, compared to the second quarter of 2008. ***The increase was primarily due to market penetration in two additional provinces through local wholesalers.***"

[1] http://finance.yahoo.com/news/Biostar-Pharmaceuticals-Inc-prnews-3257545683.html?x=0&.v=1

So, am I right is saying that there doesn't seem to be any growth in the established market? Could some of the Q2 results come from stocking up? I thinking we might have some nice growth but not some explosive growth - so explosive would be growing in all provincies it's sold as well as new provincies.

Interesting thing would be if it became more affordable under rural health initative?

cheers..

rich